Zydus Lifesciences submits press release

12 Apr 2025 Evaluate

Zydus Lifesciences has submitted a press release stating that Zydus received final approval from USFDA for Jaythari (Deflazacort) Tablets, 6 mg, 18 mg, 30 mg, and 36 mg.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

911.95 -5.50 (-0.60%)
26-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1503.00
Zydus Lifesciences 911.95
Lupin 2101.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×